Vertex Pharmaceuticals Stock Forecast

Stock Price Forecast

The 22 analysts with 12-month price forecasts for VRTX stock have an average target of 430.82, with a low estimate of 325 and a high estimate of 559. The average target predicts an increase of 9.67% from the current stock price of 392.82.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$325	$430.82	$438	$559
Change	-17.26%	+9.67%	+11.50%	+42.30%

Analyst Ratings

The average analyst rating for VRTX stock from 26 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	7	7	8	8	8	7
Buy	13	13	13	11	11	12
Hold	7	7	6	7	7	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	1	1	1	1
Total	27	27	28	27	27	26

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Debjit Chattopadhyay Guggenheim	Guggenheim	Strong Buy Maintains $445 → $450	Strong Buy	Maintains	$445 → $450	+14.56%	Apr 18, 2024
Colin Bristow UBS	UBS	Strong Buy Maintains $498 → $466	Strong Buy	Maintains	$498 → $466	+18.63%	Apr 17, 2024
Hartaj Singh Oppenheimer	Oppenheimer	Buy Maintains $500	Buy	Maintains	$500	+27.28%	Apr 15, 2024
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Strong Sell Maintains $371	Strong Sell	Maintains	$371	-5.55%	Apr 12, 2024
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $457 → $462	Strong Buy	Maintains	$457 → $462	+17.61%	Apr 11, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

10.93B

from 9.87B

10.73%

from 9.87B

Revenue Next Year

11.95B

from 10.93B

9.36%

from 10.93B

EPS This Year

17.11

from 13.89

23.21%

from 13.89

EPS Next Year

18.72

from 17.11

9.38%

from 17.11

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	4.16B	6.21B	7.57B	8.93B	9.87B	10.93B	11.95B	13.15B	13.83B	14.97B
Revenue Growth	36.59%	49.08%	22.06%	17.91%	10.51%	10.73%	9.36%	10.00%	5.21%	8.21%
EPS	4.51	10.29	9.01	12.82	13.89	17.11	18.72	20.93	21.88	22.91
EPS Growth	-44.25%	128.16%	-12.44%	42.29%	8.35%	23.21%	9.38%	11.79%	4.57%	4.69%
No. Analysts	-	-	-	-	-	35	32	23	15	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	11.5B	13.8B	15.2B	17.5B	21.3B
Avg	10.9B	12.0B	13.1B	13.8B	15.0B
Low	10.4B	10.7B	11.5B	10.7B	11.3B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	16.8%	26.0%	27.3%	33.1%	54.0%
Avg	10.7%	9.4%	10.0%	5.2%	8.2%
Low	5.2%	-1.9%	-3.9%	-19.0%	-18.4%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	19.20	21.79	26.81	31.04	27.74
Avg	17.11	18.72	20.93	21.88	22.91
Low	14.85	14.29	16.45	15.53	17.01

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	38.3%	27.3%	43.2%	48.3%	26.8%
Avg	23.2%	9.4%	11.8%	4.6%	4.7%
Low	6.9%	-16.5%	-12.1%	-25.8%	-22.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.